Home » Topics » Regulatory

Regulatory
RSS

U.K. approval for new controlled-release nifedipine based on TIMERx technology

Dec. 2, 1998

FDA approves new indications, dosing regimens for Vantin

Dec. 2, 1998

Diane-35 now available in Canada for treatment of acne

Dec. 2, 1998

Unimed receives U.S. patent protection for dronabinol in treatment of dementia

Nov. 30, 1998

SSRI promising in the treatment of children and adolescents with OCD

Nov. 30, 1998

International study focuses on riluzole as a new approach to treating PD

Nov. 30, 1998

Immunex files sBLA for Enbrel as treatment for juvenile rheumatoid arthritis

Nov. 27, 1998

Zileuton trials recommended for new indication: atopic dermatitis

Nov. 27, 1998

Continued positive results with fexofenadine in patients with CIU

Nov. 27, 1998

New treatment option for pediatric HIV/AIDS now available in U.S.

Nov. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...